Allarity Therapeutics Inc... (ALLR)
NASDAQ: ALLR
· Real-Time Price · USD
0.95
-0.03 (-3.04%)
At close: Aug 15, 2025, 3:59 PM
0.99
3.97%
After-hours: Aug 15, 2025, 07:41 PM EDT
Allarity Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 25.2M | 19.53M | 18.46M | 19.23M | 312K | 166K | 1.4M | 420K | 295K | 2.03M | 3.95M | 7.64M | 14.54M | 19.55M | 5.58M | 6.6M | 104.62K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 350K | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 254K | 314K | 350K | 491K | 641K | 698.56K |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 254K | 314K | -86K | 491K | 29.5M | 0.00 |
Receivables | 1.11M | 2.23M | n/a | 1.58M | 1.33M | 946K | 1.63M | 1.6M | 1.33M | 871K | 1.49M | n/a | 1.3M | 1.34M | 1.81M | 1.76M | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | -1.63M | 1.3M | -1.33M | n/a | 622K | n/a | -1.3M | -1.34M | 244K | n/a | n/a |
Other Current Assets | 2.61M | 72K | 1.75M | 131K | 110K | n/a | 824K | 139K | 1.02M | 1.48M | 136K | n/a | n/a | n/a | 120K | 122K | 1.61M |
Total Current Assets | 29.42M | 22.34M | 20.37M | 21.31M | 2.29M | 1.97M | 4.39M | 3.69M | 2.97M | 4.97M | 6.06M | 10.08M | 17.21M | 21.05M | 7.63M | 8.5M | 2.03M |
Property-Plant & Equipment | 308K | 309K | 12K | 17K | 18K | 20K | 29K | 26K | 25K | 27K | 46K | 47K | 71K | 94K | 117K | 141K | 165.21K |
Goodwill & Intangibles | n/a | n/a | n/a | 9.56M | 9.66M | 9.87M | 9.46M | 9.71M | 9.71M | 9.55M | 12.03M | 12.81M | 13.69M | 28.14M | 28.74M | n/a | 24.56M |
Total Long-Term Assets | 308K | 309K | 12K | 9.57M | 9.67M | 9.89M | 9.49M | 9.74M | 9.74M | 9.58M | 12.07M | 13.11M | 14.08M | 28.58M | 29.35M | 30.28M | 25.43M |
Total Assets | 29.73M | 22.65M | 20.38M | 30.88M | 11.97M | 11.86M | 13.88M | 13.43M | 12.7M | 14.54M | 18.13M | 23.19M | 31.29M | 49.63M | 36.99M | 38.78M | 27.45M |
Account Payables | 4.35M | 4.18M | 4.69M | 7.75M | 11.06M | 8.42M | 6.35M | 8.09M | 6.45M | 6.25M | 4.71M | 5.55M | 5.8M | 698K | 739K | n/a | 2.13M |
Deferred Revenue | n/a | n/a | n/a | n/a | 43K | 59K | n/a | 1.96M | n/a | n/a | n/a | n/a | n/a | 8.65M | n/a | n/a | n/a |
Short-Term Debt | 1.36M | 1.35M | 1.34M | 1.32M | 2.69M | 1.3M | n/a | 350K | 2.69M | 2.64M | 29K | 54K | 82K | n/a | 98K | 156K | 1.72M |
Other Current Liabilities | n/a | 1K | 2K | 1.18M | 3.82M | 3.99M | 9.21M | 4.02M | 2.32M | 2.06M | 7.7M | 5M | 5.35M | 18.77M | 3.25M | 4.18M | 1.78M |
Total Current Liabilities | 11.06M | 10.84M | 7.41M | 10.62M | 18.01M | 14.17M | 15.74M | 12.67M | 11.59M | 11.22M | 12.96M | 11.19M | 12.71M | 20.72M | 3.84M | 4.33M | 5.72M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | 1.17M | 1.14M | 1.11M | 1.08M | 1.06M | 1.03M | 798K | 979K | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 207K | 7.18M | 218K | 5.27M | n/a |
Total Long-Term Liabilities | n/a | n/a | n/a | 432K | 432K | 446K | 1.51M | 1.48M | 1.45M | 1.43M | 1.68M | 3.8M | 1.71M | 10.13M | 381K | 5.63M | 86.31K |
Total Liabilities | 11.06M | 10.84M | 7.41M | 11.05M | 18.44M | 14.61M | 17.25M | 14.15M | 13.04M | 12.65M | 14.63M | 14.99M | 14.42M | 30.85M | 4.22M | 9.96M | 5.81M |
Total Debt | 1.36M | 1.35M | 1.34M | 1.32M | 2.69M | 1.3M | 1.17M | 1.49M | 3.8M | 3.73M | 1.09M | 1.08M | 1.09M | 1.09M | 133K | 218K | 1.9M |
Common Stock | 2K | 1K | n/a | 3K | n/a | n/a | n/a | n/a | n/a | 2K | 1K | 929K | 885K | 810K | 3.16M | 2.85M | 1.89M |
Retained Earnings | -121.7M | -118.97M | -111.51M | -99.92M | -98.29M | -94.45M | -92.73M | -88.28M | -85.9M | -82.55M | -79.71M | -74.23M | -69.57M | -66.49M | -43.42M | -45.09M | -43.52M |
Comprehensive Income | -630K | -354K | -693K | -530K | -386K | -411K | -758K | -666K | -637K | -721K | -1.87M | -1.63M | -814K | -600K | -419K | 3.13M | 61.22K |
Shareholders Equity | 18.67M | 11.81M | 12.96M | 19.84M | -6.47M | -2.75M | -3.38M | -723K | -339K | 1.89M | 3.5M | 8.2M | 16.87M | 18.78M | 32.77M | 28.82M | 21.65M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 254K | 314K | 350K | 491K | 641K | 698.56K |